An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients
Year: 2024
Type: article
Study design: Observational Study
DOI: 10.1093/jac/dkae290
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G531131645
OpenAlex ID: W4401694880
